Mentions (24h)
Mentions (7d)
Sentiment (avg / median)
Sentiment Mix
Coverage Z-Score (24h vs 90d)
Top Sources (7d)
Co-Topics (7d)
Mentions by Hour (Last 24h)
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion
Novo Nordisk said on Thursday it agreed to buy Akero Therapeutics for up to $5.2 billion, giving the Danish drugmaker access to an experimental liver disease drug.…
CNBC Top Stories · 2025-10-09 10:40:07Costco now selling weight loss drugs Ozempic, Wegovy at a discount
Shoppers can now find Ozempic and Wegovy at Costco. It says it is partnering with drugmaker Novo Nordisk to offer the drugs at a steep discount for members with a prescription. CBS News reporter Andres Gutierrez has more.…
CBS News · 2025-10-03 23:58:00Stocks making the biggest premarket moves: Electronic Arts, Novo Nordisk, Lam Research, Oracle & more
These are the stocks posting the largest moves in premarket trading. …
CNBC Finance · 2025-09-29 12:39:08
Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating
Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, as it set the most pessimistic target price forecast of any Wall Street bank on the Da…
Market Watch · 2025-09-29 09:36:00Novo Nordisk v Eli Lilly: return of the weight-loss wars
Can the two heavyweights excite investors once again? …
Economist Business · 2025-09-25 13:30:34
Novo Nordisk’s Woes Are Slimming Denmark’s Economic Growth
Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s growth are falling, too.…
New York Times Business · 2025-09-22 04:01:17Stocks making the biggest moves midday: Intel, Novo Nordisk, Bullish, Allstate and more
These are the stocks posting the largest moves midday.…
CNBC Finance · 2025-09-18 17:50:03Stocks making the biggest premarket moves: Intel, Novo Nordisk, Bullish, Cracker Barrel and more
These are some of the stocks posting the largest moves in the premarket.…
CNBC Finance · 2025-09-18 12:47:26
Ozempic cuts heart-attack risk by nearly 25% in older patients, new study finds
The wildly popular Ozempic drug cuts heart attack, stroke and death risk by nearly 25% in older patients, according to a new study published by Novo Nordisk and released on Thursday.…
Market Watch · 2025-09-18 09:44:00Novo Nordisk shares pop 5% after Wegovy pill trial shows 'significant' weight reduction
Trial results showed the "Wegovy pill" led to average weight reduction of 16.6% after 64 weeks, Novo Nordisk said. …
CNBC Top Stories · 2025-09-18 09:28:03
